Abstract
Although more complex than usually described, the anticancer action mechanism of cisplatin is based on binding to DNA. Following this line of reasoning, most the metal-based compounds discovered soon after cisplatin were designed to acting as DNA-binding agents and their pharmacological properties were thought to be correlated with this mechanism. Apart from the DNA structure, a significant number of proteins and biochemical pathways have been described as drug targets for metal-based compounds. This paper is therefore aimed at discussing the most recent findings on the medicinal chemistry of metal-based drugs. It starts illustrating the design concept behind the bioinorganic chemistry of anticancer complexes. Anticancer metallic compounds that inhibit the protein kinases are concisely discussed as a case study. The accuracy and limitations of molecular docking programs currently available to predict the binding mode of metallic complexes in molecular targets are further discussed. Finally, the advantages and disadvantages of different in vitro screenings are briefly commented.
Keywords: Metal complexes, molecular docking, organometallics, protein kinase, ruthenium, thiosemicarbazones, triapine, Metal-Based Compounds, immunosuppressive, serendipitous process, pharmacological behaviours, biochemical mediators, metal-based drugs, selenoenzyme thioredoxin reductase, anti-Malarial ferrocene, diamino-acridine, bipyridine-acridine, diamino-amidineacridine, Gold-acridine, THIOSEMICARBAZO-NES, an anticancer prototype, HAp4pT, HDpT, HAp44mT, thiosemicarbazone (centre), HApT, PROTEIN, –, META-LLIC COMPOUNDS, (source of bio-inspiration), DOCK, Multidrug resistance/resistant, PK = Protein kinases, Pgp = P-glycoprotein, RR = Ribonucleotide Reductase, SAR = Structure-activity relationships
Current Medicinal Chemistry
Title: Recent Insights on the Medicinal Chemistry of Metal-Based Compounds: Hints for the Successful Drug Design
Volume: 17 Issue: 31
Author(s): M. Z. Hernandes, F. J.de S. Pontes, L. C.D. Coelho, D. R.M. Moreira, V. R.A. Pereira and A. C.L. Leite
Affiliation:
Keywords: Metal complexes, molecular docking, organometallics, protein kinase, ruthenium, thiosemicarbazones, triapine, Metal-Based Compounds, immunosuppressive, serendipitous process, pharmacological behaviours, biochemical mediators, metal-based drugs, selenoenzyme thioredoxin reductase, anti-Malarial ferrocene, diamino-acridine, bipyridine-acridine, diamino-amidineacridine, Gold-acridine, THIOSEMICARBAZO-NES, an anticancer prototype, HAp4pT, HDpT, HAp44mT, thiosemicarbazone (centre), HApT, PROTEIN, –, META-LLIC COMPOUNDS, (source of bio-inspiration), DOCK, Multidrug resistance/resistant, PK = Protein kinases, Pgp = P-glycoprotein, RR = Ribonucleotide Reductase, SAR = Structure-activity relationships
Abstract: Although more complex than usually described, the anticancer action mechanism of cisplatin is based on binding to DNA. Following this line of reasoning, most the metal-based compounds discovered soon after cisplatin were designed to acting as DNA-binding agents and their pharmacological properties were thought to be correlated with this mechanism. Apart from the DNA structure, a significant number of proteins and biochemical pathways have been described as drug targets for metal-based compounds. This paper is therefore aimed at discussing the most recent findings on the medicinal chemistry of metal-based drugs. It starts illustrating the design concept behind the bioinorganic chemistry of anticancer complexes. Anticancer metallic compounds that inhibit the protein kinases are concisely discussed as a case study. The accuracy and limitations of molecular docking programs currently available to predict the binding mode of metallic complexes in molecular targets are further discussed. Finally, the advantages and disadvantages of different in vitro screenings are briefly commented.
Export Options
About this article
Cite this article as:
Z. Hernandes M., J.de S. Pontes F., C.D. Coelho L., R.M. Moreira D., R.A. Pereira V. and C.L. Leite A., Recent Insights on the Medicinal Chemistry of Metal-Based Compounds: Hints for the Successful Drug Design, Current Medicinal Chemistry 2010; 17 (31) . https://dx.doi.org/10.2174/092986710793213779
DOI https://dx.doi.org/10.2174/092986710793213779 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multimerization Improves Targeting of Peptide Radio-Pharmaceuticals
Current Pharmaceutical Design Radiochemotherapy for Non Small Cell Lung Cancer
Current Drug Therapy Mast Cells as Target in Cancer Therapy
Current Pharmaceutical Design Brain Tumour Stem Cells: Implications for Cancer Therapy and Regenerative Medicine
Current Stem Cell Research & Therapy Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer
MicroRNA Editorial: Metal ions in cause, progression, treatment and diagnosis of genetic disorders, metabolic diseases and cancer
Current Drug Metabolism The Role of ING Tumor Suppressors in UV Stress Response and Melanoma Progression
Current Drug Targets Modulation of Ornithine Decarboxylase Activity by Phenolics Based Structurally Related Compounds Synthesized on Steroidal and Non-Steroidal Skeleton and their Radical Scavenging Action
Current Bioactive Compounds Anti-Cancer Drugs Targeting Fatty Acid Synthase (FAS)
Recent Patents on Anti-Cancer Drug Discovery Pharmacogenetics of Estrogen Metabolism and Transport in Relation to Cancer
Current Drug Metabolism Physico-chemical and Biological Evaluation of Flavonols: Fisetin, Quercetin and Kaempferol Alone and Incorporated in beta Cyclodextrins
Anti-Cancer Agents in Medicinal Chemistry LDH Nanocontainers as Bio-Reservoirs and Drug Delivery Carriers
Recent Patents on Nanotechnology Development of Cisplatin Nanoparticles as Dry Powder Inhalers for Lung Cancer
Current Nanoscience Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity
Medicinal Chemistry CXXC5 Associates with Smads to Mediate TNF-α Induced Apoptosis
Current Molecular Medicine The Anti-Proliferative Activity of Anisosciadone: A New Guaiane Sesquiterpene from Anisosciadium lanatum
Anti-Cancer Agents in Medicinal Chemistry Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis
Current Pharmaceutical Design Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds
Current Medicinal Chemistry Relevance of Micrometastases and Targeting the Bone Marrow Niche with Zoledronic Acid in Breast Cancer
Current Cancer Therapy Reviews Mechanism of Action and Therapeutic Potential of Novel Adamantyl Retinoid-Related Molecules
Current Cancer Therapy Reviews